These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 30555045
1. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia. Pérez-Mato M, Iglesias-Rey R, Vieites-Prado A, Dopico-López A, Argibay B, Fernández-Susavila H, da Silva-Candal A, Pérez-Díaz A, Correa-Paz C, Günther A, Ávila-Gómez P, Isabel Loza M, Baumann A, Castillo J, Sobrino T, Campos F. EBioMedicine; 2019 Jan; 39():118-131. PubMed ID: 30555045 [Abstract] [Full Text] [Related]
2. Exon-skipping splice variants of excitatory amino acid transporter-2 (EAAT2) form heteromeric complexes with full-length EAAT2. Gebhardt FM, Mitrovic AD, Gilbert DF, Vandenberg RJ, Lynch JW, Dodd PR. J Biol Chem; 2010 Oct 08; 285(41):31313-24. PubMed ID: 20688910 [Abstract] [Full Text] [Related]
3. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter. Yatomi Y, Tanaka R, Shimura H, Miyamoto N, Yamashiro K, Takanashi M, Urabe T, Hattori N. Neuroscience; 2013 Aug 06; 244():113-21. PubMed ID: 23602887 [Abstract] [Full Text] [Related]
4. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization. Foran E, Rosenblum L, Bogush A, Pasinelli P, Trotti D. Glia; 2014 Aug 06; 62(8):1241-53. PubMed ID: 24753081 [Abstract] [Full Text] [Related]
5. DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells. Zschocke J, Allritz C, Engele J, Rein T. Glia; 2007 May 06; 55(7):663-74. PubMed ID: 17311293 [Abstract] [Full Text] [Related]
6. Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L-glutamate transporter. Dunlop J, Lou Z, Zhang Y, McIlvain HB. Br J Pharmacol; 1999 Dec 06; 128(7):1485-90. PubMed ID: 10602327 [Abstract] [Full Text] [Related]
7. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I. Neurobiol Dis; 2005 Mar 06; 18(2):336-45. PubMed ID: 15686962 [Abstract] [Full Text] [Related]
8. Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases. Lin CL, Kong Q, Cuny GD, Glicksman MA. Future Med Chem; 2012 Sep 06; 4(13):1689-700. PubMed ID: 22924507 [Abstract] [Full Text] [Related]
9. Regulation of glial glutamate transporters by C-terminal domains. Leinenweber A, Machtens JP, Begemann B, Fahlke C. J Biol Chem; 2011 Jan 21; 286(3):1927-37. PubMed ID: 21097502 [Abstract] [Full Text] [Related]
10. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, Lizasoain I, Moro MA. J Cereb Blood Flow Metab; 2007 Jul 21; 27(7):1327-38. PubMed ID: 17213861 [Abstract] [Full Text] [Related]
11. Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia. Spangaro M, Bosia M, Zanoletti A, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Benedetti F, Smeraldi E, Cavallaro R. Neurosci Lett; 2012 Aug 01; 522(2):151-5. PubMed ID: 22728822 [Abstract] [Full Text] [Related]
12. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model. Falcucci RM, Wertz R, Green JL, Meucci O, Salvino J, Fontana ACK. ACS Chem Neurosci; 2019 Aug 21; 10(8):3437-3453. PubMed ID: 31257852 [Abstract] [Full Text] [Related]
13. Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke. Hurtado O, Pradillo JM, Fernández-López D, Morales JR, Sobrino T, Castillo J, Alborch E, Moro MA, Lizasoain I. Neurobiol Dis; 2008 Jan 21; 29(1):123-31. PubMed ID: 17884513 [Abstract] [Full Text] [Related]
17. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, Masuda J, Kobayashi S, Kim SU, Yamaguchi S. J Neurosci Res; 2010 Apr 21; 88(5):1017-25. PubMed ID: 19885863 [Abstract] [Full Text] [Related]
18. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke. da Silva-Candal A, Pérez-Díaz A, Santamaría M, Correa-Paz C, Rodríguez-Yáñez M, Ardá A, Pérez-Mato M, Iglesias-Rey R, Brea J, Azuaje J, Sotelo E, Sobrino T, Loza MI, Castillo J, Campos F. Ann Neurol; 2018 Aug 21; 84(2):260-273. PubMed ID: 30014516 [Abstract] [Full Text] [Related]
19. Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants. Rajatileka S, Odd D, Robinson MT, Spittle AC, Dwomoh L, Williams M, Harding D, Wagstaff M, Owen M, Crosby C, Ching J, Molnár E, Luyt K, Váradi A. Mol Neurobiol; 2018 Mar 21; 55(3):2013-2024. PubMed ID: 28271401 [Abstract] [Full Text] [Related]
20. TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning. Pradillo JM, Hurtado O, Romera C, Cárdenas A, Fernández-Tomé P, Alonso-Escolano D, Lorenzo P, Moro MA, Lizasoain I. Neuroscience; 2006 Mar 21; 138(4):1171-8. PubMed ID: 16442237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]